• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Mallinckrodt PLC

+ Add to Watchlist

MNK:US

106.0900 USD 1.3100 1.22%

As of 10:46:31 ET on 01/27/2015.

Snapshot for Mallinckrodt PLC (MNK)

Open: 106.7400 Day's Range: 106.0800 - 107.0200 Volume: 98,906
Previous Close: 107.4000 52wk Range: 54.4500 - 107.9800 1-Yr Rtn: +88.11%

Stock Chart for MNK

No chart data available.
  • MNK:US 106.1500
  • 1D
  • 1M
  • 1Y
107.4000
Interactive MNK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MNK

Current P/E Ratio (ttm) 88.5000
Estimated P/E(09/2015) 16.2064
Relative P/E vs. SPX 4.8024
Earnings Per Share (USD) (ttm) 1.2136
Est. EPS (USD) (09/2015) 6.6270
Est. PEG Ratio 0.7154
Market Cap (M USD) 12,488.31
Shares Outstanding (M) 116.28
30 Day Average Volume 1,119,084
Price/Book (mrq) 2.4811
Price/Sale (ttm) 2.6960
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth 0.00%
Next Earnings Announcement 02/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MNK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MNK

Mallinckrodt PLC develops, manufactures and markets specialty pharmaceutical products and diagnostic imaging agents. The Company specializes in the manufacturing of pain management medications. Mallinckrodt offers its products to major wholesalers and retail drug store chains around the world.

Mark C TrudeauPresident/CEOMatthew K HarbaughSenior VP/CFO
Ray FureySenior VP/Chief Compliance OfcrMario SaltarelliSenior VP/Chief Science Ofcr
More Company Profile & Key Executives for MNK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil